The landscape of cancer therapy is undergoing a transformative shift with the advent of in vivo CAR-T cell therapies. These innovative treatments promise to simplify, accelerate, and reduce the costs of cancer care, marking a significant departure from traditional ex vivo methods. This article
The groundbreaking study conducted by researchers Yang Zhang, PhD, and Jinjun Shi, PhD, from Brigham and Women's Hospital, offers promising insights into the potential of RNA nanoparticles in treating advanced prostate cancer (PCa). Their research focuses on a dual-action strategy involving
A groundbreaking discovery in cancer research has unveiled a "genetic signature" involving 177 genes that are shared across multiple cancer types, fundamentally challenging prior assumptions about the mechanisms driving cancer metastasis. These findings open new avenues for innovative
Columbus Regional Health (CRH) has recently joined the Cleveland Clinic Connected program, an esteemed initiative aimed at enhancing healthcare quality by incorporating the expertise and best practices of Cleveland Clinic, a globally recognized healthcare institution. This partnership aims to
The fight against advanced prostate cancer has taken a promising turn with the development of a new drug, NXP800. This innovative treatment aims to help patients for whom current therapies have become ineffective. By specifically targeting the heat shock factor 1 (HSF1) pathway, NXP800 addresses
Navigating the complexities of critical care clinical trials, particularly when facing the issue of "truncation due to death," is crucial for obtaining unbiased, clear, and meaningful results. Patient-centered outcomes affected by death before they can be fully measured pose significant
